J DEJONG

827 total citations
22 papers, 414 citations indexed

About

J DEJONG is a scholar working on Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, J DEJONG has authored 22 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 7 papers in Cardiology and Cardiovascular Medicine and 5 papers in Molecular Biology. Recurrent topics in J DEJONG's work include Cardiac Ischemia and Reperfusion (7 papers), Cardiac electrophysiology and arrhythmias (6 papers) and Advanced MRI Techniques and Applications (4 papers). J DEJONG is often cited by papers focused on Cardiac Ischemia and Reperfusion (7 papers), Cardiac electrophysiology and arrhythmias (6 papers) and Advanced MRI Techniques and Applications (4 papers). J DEJONG collaborates with scholars based in Netherlands, United States and Italy. J DEJONG's co-authors include Alec Roy, M. Linnoila, Danuta M. Lamparski, H. Stam, Eef Harmsen, P VERDOUW, Willem J. Remme, Peter Achterberg, Elisabeth Keijzer and M Wasilewski and has published in prestigious journals such as Journal of Biological Chemistry, American Journal of Psychiatry and Biochimica et Biophysica Acta (BBA) - General Subjects.

In The Last Decade

J DEJONG

19 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J DEJONG Netherlands 11 122 101 92 80 71 22 414
Matthew J. Lennon Australia 10 11 0.1× 30 0.3× 56 0.6× 58 0.7× 130 1.8× 23 611
Alexander Glahn Germany 12 99 0.8× 110 1.1× 14 0.2× 86 1.1× 123 1.7× 41 468
R Ponnudurai India 10 111 0.9× 11 0.1× 18 0.2× 28 0.3× 28 0.4× 39 418
Adityanjee India 12 103 0.8× 15 0.1× 78 0.8× 22 0.3× 26 0.4× 28 454
Philippe Pfeifer Switzerland 11 54 0.4× 36 0.4× 12 0.1× 43 0.5× 26 0.4× 23 313
Stephen Crawford United States 10 22 0.2× 9 0.1× 81 0.9× 105 1.3× 149 2.1× 19 609
S Kropp Germany 9 23 0.2× 21 0.2× 58 0.6× 51 0.6× 126 1.8× 19 435
Christopher L. Sola United States 12 52 0.4× 10 0.1× 188 2.0× 29 0.4× 34 0.5× 23 619
D L Roberts United States 10 27 0.2× 17 0.2× 53 0.6× 6 0.1× 29 0.4× 16 438
Xuejia Song China 10 74 0.6× 12 0.1× 24 0.3× 38 0.5× 60 0.8× 17 417

Countries citing papers authored by J DEJONG

Since Specialization
Citations

This map shows the geographic impact of J DEJONG's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J DEJONG with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J DEJONG more than expected).

Fields of papers citing papers by J DEJONG

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J DEJONG. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J DEJONG. The network helps show where J DEJONG may publish in the future.

Co-authorship network of co-authors of J DEJONG

This figure shows the co-authorship network connecting the top 25 collaborators of J DEJONG. A scholar is included among the top collaborators of J DEJONG based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J DEJONG. J DEJONG is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kropff, Jort, J DEJONG, Simone Del Favero, et al.. (2016). Psychological outcomes of evening and night closed‐loop insulin delivery under free living conditions in people with Type 1 diabetes: a 2‐month randomized crossover trial. Diabetic Medicine. 34(2). 262–271. 29 indexed citations
2.
Linnoila, M., J DEJONG, & Matti Virkkunen. (2014). Monoamines, Glucose Metabolism and Impulse Control. PubMed. 25(3). 236–260. 5 indexed citations
3.
DEJONG, J, et al.. (2004). A single social defeat induces short-lasting behavioral sensitization to amphetamine. Physiology & Behavior. 83(5). 805–811. 32 indexed citations
4.
DEJONG, J, Silvia Bradamante, Salvatore Curello, et al.. (1995). Intermittent v continuous ischernia decelerates adenylate breakdown and prevents norepinephrine release in reperfused rabbit heart. Journal of Molecular and Cellular Cardiology. 27(1). 659–671. 17 indexed citations
5.
Bernstein, Richard A., J DEJONG, & Robert G. Roeder. (1994). Characterization of the highly conserved TFIIA small subunit from Drosophila melanogaster.. Journal of Biological Chemistry. 269(39). 24361–24366. 7 indexed citations
6.
DEJONG, J, et al.. (1990). Ischemic nucleotide breakdown increases during cardiac development due to drop in adenosine anabolism/catabolism ratio. Journal of Molecular and Cellular Cardiology. 22(10). 1065–1070. 20 indexed citations
7.
Roy, Alec, et al.. (1990). CSF gamma-aminobutyric acid in alcoholics and control subjects. American Journal of Psychiatry. 147(10). 1294–1296. 11 indexed citations
8.
Roy, Alec, et al.. (1990). Characteristics of alcoholics who attempt suicide. American Journal of Psychiatry. 147(6). 761–765. 131 indexed citations
9.
DEJONG, J. (1990). The role of energy metabolism in postischemic damage. Journal of Molecular and Cellular Cardiology. 22. 40–40. 1 indexed citations
10.
DEJONG, J, et al.. (1987). Inosine infusion in isolated rat heart: Effect on flow, function and catabolism. Journal of Molecular and Cellular Cardiology. 19. S99–S99.
11.
DEJONG, J, et al.. (1987). Myocardial adenosine kinase activity decreases with age. Journal of Molecular and Cellular Cardiology. 19. S16–S16. 1 indexed citations
12.
DEJONG, J & Tom Huizer. (1986). Dose-dependent suppression of purine production in ischemic heart by bepridil. Journal of Molecular and Cellular Cardiology. 18. 127–127. 1 indexed citations
13.
Keijzer, Elisabeth, et al.. (1986). Heart xanthine oxidoreuductase activity increases with age; The enzyme is absent frommyocytes. Journal of Molecular and Cellular Cardiology. 18. 62–62. 1 indexed citations
14.
Achterberg, Peter, et al.. (1986). Developmental differences in myocardial ATP-metabolism*. Journal of Molecular and Cellular Cardiology. 18. 24–24. 1 indexed citations
15.
DEJONG, J, et al.. (1985). Adenine nucleotide catabolism in ischemic heart prevented by the calcium antagonist nisoldipine. Journal of Molecular and Cellular Cardiology. 17. 22–22. 1 indexed citations
16.
Achterberg, Peter, et al.. (1985). Myocardial S-adenosylhomocysteine hydrolase is important for adenosine production during normoxia. Biochimica et Biophysica Acta (BBA) - General Subjects. 840(3). 393–400. 26 indexed citations
17.
DEJONG, J, et al.. (1984). Diltiazem administered before or during myocardial ischemia decreases adenine nucleotide catabolism. Journal of Molecular and Cellular Cardiology. 16(4). 363–370. 34 indexed citations
18.
DEJONG, J, P VERDOUW, & Willem J. Remme. (1977). Myocardial nucleoside and carbohydrate metabolism and hemodynamics during partial occlusion and reperfusion of pig coronary artery. Journal of Molecular and Cellular Cardiology. 9(4). 297–312. 26 indexed citations
19.
Stam, H. & J DEJONG. (1977). Sephadex-induced reduction of coronary flow in the isolated rat heart: A model for ischemic heart disease. Journal of Molecular and Cellular Cardiology. 9(8). 633–IN1. 40 indexed citations
20.
DEJONG, J. (1972). Phosphorylation and deamination of adenosine by the isolated, perfused rat heart. Biochimica et Biophysica Acta (BBA) - General Subjects. 286(2). 252–259. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026